Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

The two drugs are metformin, one of the most widely used diabetes medications, and the GLP-1 class of medications that ...

Real-world data on GLP-1R agonists’ safety in heart failure and CKD patients was investigated using the TriNetX Research ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

The two drugs are metformin, one of the most widely used diabetes medications, and the GLP-1 class of medications that ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

华东医药另一个获批临床试验的产品DR10624注射液为道尔生物自主研发的一款长效三靶点激动剂，适应症为代谢相关脂肪性肝病/代谢相关脂肪性肝炎。截至目前全球尚无同时靶向FGF21R、GLP-1R和GCGR的长效三靶点激动剂药物上市，DR10624注射液具有“first-in-class”潜力。

作者：周绘出品：洞察IPO上交所ShangHai&深交所ShenZhen 新 股 上 ...

With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive ...